Value-based care provider NuvoAir is partnering with the ALS Association to provide virtual pulmonary care to individuals with ALS, starting with two clinics in Texas.
ALS is a nervous system disorder that affects motor neurons, which are nerve cells in the spinal cord and brain that control breathing and voluntary muscle movement. Individuals with ALS often experience respiratory complications...
AI-powered third-party administrator Marpai announced it would add value-based care provider NuvoAir, a virtual-first specialty care provider focused on managing patients with complex heart and lung conditions, to its Marpai Connect platform.
NuvoAir offers same-day virtual care appointments to individuals with cardiopulmonary conditions, such as chronic obstructive pulmonary disease, chronic...
Wheel, a virtual care staffing and services vendor, raised $150 million in a Series C funding round led by Lightspeed Venture Partners and Tiger Global.
Other investors participating in the round include Coatue, Salesforce Ventures, CRV, Tusk Venture Partners and Silverton Partners. The Series C comes less than a year after a $50 million round from May, and brings the company's total raise to $...
HypnoVR raises €4.5M to accelerate roll-out of digital therapy
French digital therapeutics firm HypnoVR has raised €4.5 million in Series A funding for its virtual reality-based medical hypnosis solution for pain and anxiety.
The round was led by Theodorus, the Banque des Territoires operating for the French state as part of the Investments for the Future Programme, Akiles and Capital Grand...
Stockholm-based digital health company NuvoAir has raised $12 million (€10M) to expand its chronic disease management and clinical trial platforms.
The Series A funding round was led by AlbionVC and comes off the back of a record 500% growth for NuvoAir in the first quarter of 2021.
KAYA (formerly Enern), Amino Collective and existing shareholders Spiltan, Industrifonden and Novartis Pharma AG (...
Stockholm-based respiratory health startup NuvoAir is rolling out a new app that can record coughs in a home setting in order to help clinicians detect possible conditions like asthma and COPD.
Called NuvoAir Cough, the app will include an AI-backed algorithm that can detect a cough or burst of coughs and send that information to the user's care team. Clinicians can access information about their...
Studies on paediatric pulmonology from the UK and Sweden have demonstrated that both young and adult patients with respiratory disease can achieve good quality spirometry at home, without clinical supervision, when using the NuvoAir Home platform.
The platform includes in-app coaching which provides feedback on techniques to support quality measurements.
Other key findings show that patient...
Sweden-based digital therapeutics respiratory company, NuvoAir, has been certified as a Class Im medical device.
The NuvoAir Home platform includes Air Next, a certified bluetooth spirometer, a connected patient app and a healthcare portal.
WHY IT MATTERS
Patients can use the platform to self-monitor their respiratory health and share clinically relevant data with their care teams, who can view...
Respiratory monitor maker NuvoAir (formerly Pond Healthcare Innovation) has picked up its first FDA 510(k) for Air Next, a portable and connected home-use spirometer device.
According to the FDA’s premarket notification database, the Stockholm, Sweden-based company submitted its application in November 2018, and received the decision last Thursday.
The Air Next is designed for patients with...
Stockholm-based respiratory health startup NuvoAir is set to make its technology available in selected cystic fibrosis (CF) centres after entering a new partnership with Roche Italy.
This marks NuvoAir’s first CF deal with a pharma company.
WHY IT MATTERS
According to the UK-based Cystic Fibrosis Trust, the genetic condition is estimated to affect around 100,000 people globally. It causes a...
